Get started
Author

Ying Liu

Observed institutions: Guangzhou University of Chinese Medicine, Sun Yat-sen University, Chinese Academy of Medical Sciences & Peking Union Medical College, Fudan University, Inner Mongolia University of Science and Technology, Nanfang Hospital, First People's Hospital of Foshan, First Hospital of Jilin University, Zhongshan Hospital, The First Affiliated Hospital, Sun Yat-sen University, Affiliated Zhongshan Hospital of Dalian University, Third Affiliated Hospital of Sun Yat-sen University, Beijing Friendship Hospital, Beijing Tsinghua Chang Gung Hospital, First Affiliated Hospital of Zhengzhou University, First Affiliated Hospital of Jinan University, Indiana University School of Medicine, Southern Medical University, Tsinghua University
ORCID: 0000-0002-7529-0917
Observed ORCID: 0000-0002-7529-0917
OpenAlex ID: A5100414341
Pretransplant use of immune checkpoint inhibitors for hepatocellular carcinoma: A multicenter, retrospective cohort study
2024 · Zhiyong Guo, Yao Liu, et al. · American Journal of Transplantation · 74
PDF
Up-Regulation of Hepatitis C Virus Replication and Production by Inhibition of MEK/ERK Signaling
2009 · Jean Ndjomou, In-woo Park, et al. · PLoS ONE · 22
PDF
Canthaxanthin shows anti-liver aging and anti-liver fibrosis effects by down-regulating inflammation and oxidative stress in vivo and in vitro
2022 · Jiarui Li, Lei Xian, et al. · International Immunopharmacology · 20
Intermediate stage hepatocellular carcinoma: Comparison of the value of inflammation-based scores in predicting progression-free survival of patients receiving transarterial chemoembolization
2021 · Ying Liu, Menting Shi, et al. · Journal of Cancer Research and Therapeutics · 20
RETRACTED: Salvage liver transplantation for hepatocellular carcinoma recurrence after primary liver resection
2014 · Wei Qu, Zhi-Jun Zhu, et al. · Clinics and Research in Hepatology and Gastroenterology · 15
Efficacy and safety of hepatic artery infusion chemotherapy with mFOLFOX in primary liver cancer patients with hyperbilirubinemia and ineffective drainage: a retrospective cohort study
2022 · Tianxiao Wang, Jiahong Dong, et al. · Annals of Translational Medicine · 14
PDF
Naturally occurring drug resistance associated variants to hepatitis C virus direct-acting antiviral agents in treatment-naive HCV genotype 1b-infected patients in China
2017 · Zhanyi Li, Ying Zhang, et al. · Medicine · 13
c-Met/MAPK pathway promotes the malignant progression of residual hepatocellular carcinoma cells after insufficient radiofrequency ablation
2020 · Guoqun Jia, Fengjuan Li, et al. · Medical Oncology · 10
350–560 μm gelatin sponge particles combined with transcatheter arterial chemoembolization for the treatment of elderly hepatocellular carcinoma: The safety and efficacy
2017 · Guang Sheng Zhao, Chuang Li, et al. · Medicine · 8
Complete remission of diffuse hepatocellular carcinoma in a young adult after GSP-TACE: a case report
2014 · Song Liu, Yuewei Zhang, et al. · World Journal of Surgical Oncology · 8
PDF
Exploratory study of microparticle transcatheter arterial chemoembolization combined with resection for huge hepatocellular carcinoma
2022 · Ying Liu, Yaqin Wang, et al. · iLiver · 7
PDF
Different doses of partial liver irradiation promotes hepatic regeneration in rat.
2015 · Ying Liu, Changzheng Shi, et al. · Europe PMC (PubMed Central) · 7
Assessment of efficacy and prognostic factors by Gelfoam for DEB-TACE in unresectable large hepatocellular carcinoma with portal vein tumor thrombus: a multi-center retrospective study
2022 · Guang Sheng Zhao, Song Liu, et al. · Expert Review of Gastroenterology & Hepatology · 6
New Non-Nucleocide NS5B Protein Inhibitors for the Treatment of Chronic Hepatitis C Infection
2016 · Li-hong Shan, Ying Liu, et al. · Current Topics in Medicinal Chemistry · 5
CalliSpheres® microsphere transarterial chemoembolization combined with 125I brachytherapy for patients with non–small‐cell lung cancer liver metastases
2022 · Guangsheng Zhao, Song Liu, et al. · Frontiers in Oncology · 4
Correlation analysis between plasma concentration of nilotinib and clinical efficacy and safety in patients with chronic myeloid leukemia: a single–center retrospective cohort study
2025 · Ying Liu, Taoyan Lin, et al. · Frontiers in Pharmacology · 2
PDF
A novel nomogram based on GD for predicting prognosis in hepatocellular carcinoma
2023 · Ying Liu, Kang Cui, et al. · Frontiers in Oncology · 2
PDF
Correction: Correlation analysis between plasma concentration of nilotinib and clinical efficacy and safety in patients with chronic myeloid leukemia: a single–center retrospective cohort study
2025 · Ying Liu, Taoyan Lin, et al. · Frontiers in Pharmacology
PDF
MOR/ERK signalling pathway promotes the malignant progression of residual hepatocellular carcinoma cells after insufficient radiofrequency ablation
2025 · Qianxi Yin, Fengjuan Li, et al. · Journal of Contemporary Medical Sciences
Comparative effectiveness of adjuvant treatment for curative resected hepatocellular carcinoma: A network meta-analysis
2020 · Ying Liu, Yuzhu Wang, et al.
PDF
Works count: 20
Citation count: 237
H-index: 8
I10-index: 8
Year
Topic
Type